Fibrinopeptide a (FPA) levels in atrial fibrillation and the effects of heparin administration

JAPANESE CIRCULATION JOURNAL

Volumn 52, Issue 1, 1988, Pages 9-12

  Uno, Masashi ^a   Sawada, Shohei ^a   Toyoda, Takeo ^a   Akagawa, Masao ^a   Tsuji, Hajime ^b  

^a Gifu University   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Antithrombin III; Atrial fibrillation; Fibrinopeptide A; Subcutaneous heparin administration; Thromboembolism

Indexed keywords

ANTITHROMBIN III; FIBRINOPEPTIDE; HEPARIN;

ADULT; CLINICAL ARTICLE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MALE; MITRAL VALVE STENOSIS; PLASMA;

ATRIAL FIBRILLATION; FIBRINOGEN; FIBRINOPEPTIDE A; HEPARIN; HUMAN; HYPERTENSION; MITRAL VALVE STENOSIS;

EID: 0023903982     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.52.9     Document Type: Article

References (11)

1. TOY JL, LEDERER DA, TULPULE AT, et al.: Coagulation studies in rheumatic heart disease. Br Heart J 43: 301, 1980.
2. BLOMBACK B, BLOMBACK M, EDMAN P, HESSEL B: Human fibrinopeptide isolation, characterization and structure. Biochem Biophys Acta 115: 371, 1966.
3. HIRSH J: Effectiveness of Anticoagulants. Semin Throm Hemost 12 (2): 21, 1986.
4. HUBBARD AR, JENNINGS CA, BARROWCLIFFE TW: Anticoagulant properties in vitro of heparin sulfates. Thromb Res 35: 567, 1984.
5. NOSSEL HL, YUDELMAN I, CANFIELD RE, et al.: Measurement of fibrinopeptide A in human blood. J Clin Invest 54: 43, 1974.
6. LEVINE HJ: Which atrial fibrillation patients should be on chronic anticoagulation? J Cardiovasc Med 6: 1483, 1981.
7. COULSHED N, EPSTEIN EJ, MCKENDRICK CS, GALLOWAY RW, WALKER E: Systemic embolism in mitral valve disease. Br Heart J 32: 26, 1970.
8. FLEMING HA, BAILEY SM: Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 47: 599, 1971.
9. CASELLA L, ABELMANN WH, ELLIS LB: Patients with mitral stenosis and systemic emboli. Arch Intern Med 114: 773, 1964.
10. NAKAGAWA, M, TSUJI H, MAEBO N, et al.: Congenital and Acquired Antithrombin III Deficiency. Acta Haemat Jpn 48: 8: 209, 1985.
11. DREWINKO B, SCHMIDT D, BOLLINGER P, JOHNSTON D, TRUJILLO JM: Fibrinopeptide A: Evaluation of a Commercial RIA Kit and Values for Normal Population. J Med Tech 2: 9 September 1985.